Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells

Published:2010-07-26 Issue:3 Volume:222 Page:249-260
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Zhuo Wei,Luo Chong,Wang Xiaofeng,Song Xiaomin,Fu Yan,Luo Yongzhang

Funder

General Programs of the National Natural Science Foundation of China

Major Program of the National Natural Science Foundation of China

National High Technology Research and Development Program of China

State Key Development Program for Basic Research of China

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/path.2760/fullpdf

Reference46 articles.

1. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth;O'Reilly;Cell,1997

2. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding;Yamaguchi;EMBO J,1999

3. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance;Boehm;Nature,1997

4. Phase I study of recombinant human endostatin in patients with advanced solid tumors;Herbst;J Clin Oncol,2002

5. Endostatin's antiangiogenic signaling network;Abdollahi;Mol Cell,2004

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives;Signal Transduction and Targeted Therapy;2024-08-02

2. AS1411 aptamer tagged PEGylated liposomes as a smart nanocarrier for tumor-specific delivery of Withaferin A for mitigating pulmonary metastasis;Biomaterials Advances;2023-11

3. A real-world study of recombinant human endostatin combined with PD-1/PD-L1 blockade and chemotherapy for patients with advanced non-small cell lung cancer negative for actionable molecular biomarkers;Medicine;2023-10-13

4. Gold nanoparticles as antiangiogenic and antimetastatic agents;Drug Discovery Today;2023-02

5. Nucleolin; A tumor associated antigen as a potential lung cancer biomarker;Pathology - Research and Practice;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3